Surviving a Decade: Prolonged Survival in Metastatic HER2- Positive Breast Cancer through Continuous HER2 Blockade - Abstract
HER2 receptor is overexpressed and/or amplified in 15-
20% of malignant breast tumors, and this is associated with a
more aggressive disease course [1].